Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Informing global polio eradication efforts through…

U.S. Centers for Disease Control-GHC·United States of America

Informing global polio eradication efforts through innovative modeling approaches

Closes 3/13/2027$1.8M – $2.2MGrants Notice
Get bids like this by emailBid source

Description

This forecasted Funding Opportunity Announcement (NOFO) seeks a lead research team to develop and apply advanced statistical and mathematical models that will guide global polio eradication strategies. The effort will focus on cVDPV2 outbreak response, post‑eradication surveillance, and containment breach detection, while also building modeling capacity among public‑health professionals and graduate students. The award will be a single cooperative agreement with an estimated total funding of $2 million. • Scope: Design, implement, and validate disease‑transmission models for poliovirus (cVDPV2 and WPV). • Deliverables: Modeling tools, policy‑relevant scenario analyses, economic impact assessments, and training modules for a diverse public‑health workforce. • Eligibility: Open to a wide range of entities (state, local, tribal, nonprofit, for‑profit, higher‑education institutions, etc.). • Funding Instrument: Cooperative Agreement (CFDA 93.185). • Timeline: Applications due 02/12/2027; award expected 08/01/2027; project start 09/01/2027. • Expected duration: Not explicitly stated but typical CDC research grants run 1–3 years.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Julie Jenks

[email protected]

(404) 718-2794

Key dates

Opened
8/31/2026
Closes
3/13/2027
Projected award
8/1/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541711
Solicitation №
CDC-RFA-JG-27-0077

Budget estimate

$1,800,000 – $2,200,000

The forecast lists an estimated total funding of $2,000,000 for a single award. Assuming typical CDC cooperative agreements allocate 90‑110 % of the estimate to cover overhead, personnel, and subcontracting, the likely budget range for the prime recipient would be roughly $1.8 M to $2.2 M. Factors influencing the final amount include the exact scope of modeling work, number of sub‑awards for training components, and any cost‑sharing requirements (which are noted as false for this opportunity).

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Centers for Disease Control and Prevention - ERA·United States of America

Top match · 83%

Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network

Closes 1/29/2027Opened 7/28/2026

U.S. Centers for Disease Control-GHC·United States of America

82% match

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

Closes 3/13/2027Opened 8/31/2026

U.S. Centers for Disease Control - NCEZID·United States of America

81% match

DHQP Global NOFO

Closes 6/18/2027Opened 8/3/2026

U.S. National Institutes of Health·United States of America

81% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

81% match

Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

Closes 11/5/2026Opened 8/1/2025

U.S. Centers for Disease Control-GHC·United States of America

81% match

Capacity Building for Global, Regional, and National Immunization Programs

Closes 3/13/2027Opened 8/14/2026

U.S. National Institutes of Health·United States of America

80% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

80% match

Centers for Research on Neglected Infectious Diseases

Closes 6/14/2027Opened 10/6/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

80% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 2/5/2027Opened 9/3/2026

U.S. Centers for Disease Control - NCIPC·United States of America

80% match

Supporting Community Application of Life-Saving Evidence to Prevent Injury and Violence (SCALE)

Closes 5/5/2027Opened 9/1/2026

U.S. National Institutes of Health·United States of America

79% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

79% match

Chronic Disease Education and Awareness

Closes 4/29/2027Opened 10/9/2026

U.S. Department Of Health And Human Services·United States of America

79% match

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Closes 12/8/2026Opened 10/9/2026

U.S. Centers for Disease Control - NCIPC·United States of America

79% match

Modernizing Violent Death and Suicide Surveillance Using the National Violent Death Reporting System (NVDRS)

Closes 6/2/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

78% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

78% match

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)

Closes 10/27/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

78% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

78% match

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 12/29/2025

U.S. National Institutes of Health·United States of America

78% match

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)

Closes 1/7/2027Opened 10/12/2023

U.S. National Institutes of Health·United States of America

78% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

78% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

78% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

78% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

78% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

77% match

Expanded Surveillance for Pediatric Infectious Diseases

Closes 1/29/2027Opened 7/28/2026